General Information of Drug Off-Target (DOT) (ID: OTH5YKSL)

DOT Name Copine-1 (CPNE1)
Synonyms Chromobindin 17; Copine I
Gene Name CPNE1
Related Disease
Castration-resistant prostate carcinoma ( )
Lung cancer ( )
Lung carcinoma ( )
Neoplasm ( )
Non-small-cell lung cancer ( )
Open-angle glaucoma ( )
Prostate cancer ( )
Prostate carcinoma ( )
Bone osteosarcoma ( )
Osteosarcoma ( )
UniProt ID
CPNE1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00168 ; PF07002
Sequence
MAHCVTLVQLSISCDHLIDKDIGSKSDPLCVLLQDVGGGSWAELGRTERVRNCSSPEFSK
TLQLEYRFETVQKLRFGIYDIDNKTPELRDDDFLGGAECSLGQIVSSQVLTLPLMLKPGK
PAGRGTITVSAQELKDNRVVTMEVEARNLDKKDFLGKSDPFLEFFRQGDGKWHLVYRSEV
IKNNLNPTWKRFSVPVQHFCGGNPSTPIQVQCSDYDSDGSHDLIGTFHTSLAQLQAVPAE
FECIHPEKQQKKKSYKNSGTIRVKICRVETEYSFLDYVMGGCQINFTVGVDFTGSNGDPS
SPDSLHYLSPTGVNEYLMALWSVGSVVQDYDSDKLFPAFGFGAQVPPDWQVSHEFALNFN
PSNPYCAGIQGIVDAYRQALPQVRLYGPTNFAPIINHVARFAAQAAHQGTASQYFMLLLL
TDGAVTDVEATREAVVRASNLPMSVIIVGVGGADFEAMEQLDADGGPLHTRSGQAAARDI
VQFVPYRRFQNAPREALAQTVLAEVPTQLVSYFRAQGWAPLKPLPPSAKDPAQAPQA
Function
Calcium-dependent phospholipid-binding protein that plays a role in calcium-mediated intracellular processes. Involved in the TNF-alpha receptor signaling pathway in a calcium-dependent manner. Exhibits calcium-dependent phospholipid binding properties. Plays a role in neuronal progenitor cell differentiation; induces neurite outgrowth via a AKT-dependent signaling cascade and calcium-independent manner. May recruit target proteins to the cell membrane in a calcium-dependent manner. May function in membrane trafficking. Involved in TNF-alpha-induced NF-kappa-B transcriptional repression by inducing endoprotease processing of the transcription factor NF-kappa-B p65/RELA subunit. Also induces endoprotease processing of NF-kappa-B p50/NFKB1, p52/NFKB2, RELB and REL.
Tissue Specificity Expressed in neutrophils (at protein level) . Widely expressed. Expressed in the brain. Expressed in neutrophil precursors from bone marrow and peripheral blood .
Reactome Pathway
Neutrophil degranulation (R-HSA-6798695 )
Glycerophospholipid biosynthesis (R-HSA-1483206 )

Molecular Interaction Atlas (MIA) of This DOT

10 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Castration-resistant prostate carcinoma DISVGAE6 Strong Altered Expression [1]
Lung cancer DISCM4YA Strong Biomarker [2]
Lung carcinoma DISTR26C Strong Biomarker [2]
Neoplasm DISZKGEW Strong Altered Expression [1]
Non-small-cell lung cancer DIS5Y6R9 Strong Biomarker [2]
Open-angle glaucoma DISSZEE8 Strong Altered Expression [3]
Prostate cancer DISF190Y Strong Altered Expression [1]
Prostate carcinoma DISMJPLE Strong Altered Expression [1]
Bone osteosarcoma DIST1004 Limited Biomarker [4]
Osteosarcoma DISLQ7E2 Limited Biomarker [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
12 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Copine-1 (CPNE1). [5]
Cisplatin DMRHGI9 Approved Cisplatin affects the expression of Copine-1 (CPNE1). [6]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Copine-1 (CPNE1). [7]
Temozolomide DMKECZD Approved Temozolomide decreases the expression of Copine-1 (CPNE1). [8]
Decitabine DMQL8XJ Approved Decitabine affects the expression of Copine-1 (CPNE1). [6]
Aspirin DM672AH Approved Aspirin increases the expression of Copine-1 (CPNE1). [9]
Clozapine DMFC71L Approved Clozapine decreases the expression of Copine-1 (CPNE1). [10]
Sulindac DM2QHZU Approved Sulindac decreases the expression of Copine-1 (CPNE1). [9]
Tocopherol DMBIJZ6 Phase 2 Tocopherol increases the expression of Copine-1 (CPNE1). [11]
THAPSIGARGIN DMDMQIE Preclinical THAPSIGARGIN decreases the expression of Copine-1 (CPNE1). [14]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Copine-1 (CPNE1). [15]
CH-223191 DMMJZYC Investigative CH-223191 decreases the expression of Copine-1 (CPNE1). [16]
------------------------------------------------------------------------------------
⏷ Show the Full List of 12 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Copine-1 (CPNE1). [12]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Protein Interaction/Cellular Processes of This DOT
Drug Name Drug ID Highest Status Interaction REF
PMID28870136-Compound-48 DMPIM9L Patented PMID28870136-Compound-48 affects the binding of Copine-1 (CPNE1). [13]
------------------------------------------------------------------------------------

References

1 CPNE1 Is a Useful Prognostic Marker and Is Associated with TNF Receptor-Associated Factor 2 (TRAF2) Expression in Prostate Cancer.Med Sci Monit. 2017 Nov 19;23:5504-5514. doi: 10.12659/msm.904720.
2 High expression of Copine1 promotes cell growth and metastasis in human lung adenocarcinoma.Int J Oncol. 2018 Dec;53(6):2369-2378. doi: 10.3892/ijo.2018.4558. Epub 2018 Sep 12.
3 Upregulation of Copine1 in trabecular meshwork cells of POAG patients: a membrane proteomics approach.Mol Vis. 2008 May 30;14:1028-36.
4 CPNE1 silencing inhibits the proliferation, invasion and migration of human osteosarcoma cells.Oncol Rep. 2018 Feb;39(2):643-650. doi: 10.3892/or.2017.6128. Epub 2017 Dec 4.
5 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
6 Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7(12):e53003. doi: 10.1371/journal.pone.0053003. Epub 2012 Dec 27.
7 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
8 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
9 Expression profile analysis of colon cancer cells in response to sulindac or aspirin. Biochem Biophys Res Commun. 2002 Mar 29;292(2):498-512.
10 Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021.
11 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
12 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
13 Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun. 2008 Dec 19;377(3):797-802.
14 Proteomic signatures in thapsigargin-treated hepatoma cells. Chem Res Toxicol. 2011 Aug 15;24(8):1215-22. doi: 10.1021/tx200109y. Epub 2011 Jul 1.
15 Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. Environ Int. 2021 Nov;156:106730. doi: 10.1016/j.envint.2021.106730. Epub 2021 Jun 27.
16 Adaptive changes in global gene expression profile of lung carcinoma A549 cells acutely exposed to distinct types of AhR ligands. Toxicol Lett. 2018 Aug;292:162-174.